CCL23 is a potent chemoattractant for myeloid cells that stimulates chemotactic migration of endothelial cells to support tumor angiogenesis in ovarian tumors and increases the proportion of exhausted CD8+ T-cells in the TME [12,13,14]. Here, CCL23 is linked to ovarian neoplasm.